XSHE
002145
Market cap2.66bUSD
Oct 09, Last price
4.74CNY
1D
1.50%
1Q
9.72%
Jan 2017
12.06%
IPO
-36.63%
Name
CNNC Hua Yuan Titanium Dioxide Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Tinergy Chemical Co., Ltd., together with its associated entities, specializes in the innovation, manufacture, and distribution of titanium dioxide and a diverse array of other commodities, serving both domestic Chinese and international markets. The company's offerings extend to various inorganic chemical substances, such as ferrous sulfate, phosphate rock, yellow phosphorus, and ferrous phosphate, alongside modified polyacrylamide and sulfuric acid slag. Additionally, Tinergy provides chemical apparatus, as well as logistical and transportation services. Its operations also include electricity generation from waste heat, and the provision of technological development, advisory, and licensing services. Founded in 2001 and based in Baiyin, China, the corporation was previously identified as CNNC Hua Yuan Titanium Dioxide Co., Ltd. before officially changing its name to Tinergy Chemical Co., Ltd. in October 2025.
Key people
Qiuli Yuan
Chairman of the Board, President · since 2024
Yonggang Feng
Vice President · since 2024
Qingyuan Liu
Vice President · since 2024
Xuxiang Pan
Vice President · since 2019
Chen Qu
Chief Financial Officer, Vice President · since 2024
Xinyu Xie
Vice President, Director · since 2023
Benfa Zhang
Chief Engineer · since 2020
Yuan Zhou
Secretary of the Board, Director · since 2024
Peipei Ning
Staff Elected Director · since 2025
Xin Shen
Vice Chairman of the Board · since 2023
Shunmin Wang
President, Director · since 2025
Yikun Yu
Vice President, Director · since 2020
Xiaohua Su
Independent Director · since 2024
Longqing Zhang
Independent Director · since 2024
Boquan Zheng
Independent Director · since 2024
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||||
Revenues | |||||||||||
Cost of revenue | |||||||||||
Unusual Expense (Income) | |||||||||||
NOPBT | |||||||||||
NOPBT Margin | |||||||||||
Operating Taxes | |||||||||||
Tax Rate | |||||||||||
NOPAT | |||||||||||
Net income | |||||||||||
Dividends | |||||||||||
Dividend yield | |||||||||||
Proceeds from repurchase of equity | |||||||||||
BB yield | |||||||||||
| Debt | |||||||||||
Debt current | |||||||||||
Long-term debt | |||||||||||
Deferred revenue | |||||||||||
Other long-term liabilities | |||||||||||
Net debt | |||||||||||
| Cash flow | |||||||||||
Cash from operating activities | |||||||||||
CAPEX | |||||||||||
Cash from investing activities | |||||||||||
Cash from financing activities | |||||||||||
FCF | |||||||||||
| Balance | |||||||||||
Cash | |||||||||||
Long term investments | |||||||||||
Excess cash | |||||||||||
Stockholders' equity | |||||||||||
Invested Capital | |||||||||||
ROIC | |||||||||||
ROCE | |||||||||||
| EV | |||||||||||
Common stock shares outstanding | |||||||||||
Price | |||||||||||
Market cap | |||||||||||
EV | |||||||||||
EBITDA | |||||||||||
EV/EBITDA | |||||||||||
Interest | |||||||||||
Interest/NOPBT | |||||||||||